Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial

Background: This study was conducted to evaluate the safety and tolerability, and population pharmacokinetics (PPK) of montelukast as well as efficacy in the treatment of perennial allergic rhinitis (PAR) in paediatric Japanese patients aged between 1 and 15 years. Methods: In this multi-centre, ope...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Drug Assess
Prif Awduron: Okubo, Kimihiro, Inoue, Yoichi, Numaguchi, Hirotaka, Tanaka, Kumi, Saito, Itori, Oshima, Nobuyuki, Matsumoto, Yuki, Prohn, Marita, Mehta, Anish, Nishida, Chisato, Philip, George
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2016
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040008/
https://ncbi.nlm.nih.gov/pubmed/27785374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2016.1209507
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg